Therapeutic Biopharma (1,910 companies)
977 Companies
Access all companiesSpotfolio tracks over one million companies in technology industries.
There are 977 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Therapeutic, Patients, Treatment, Research, Pharmaceutical, Disease .
Start-ups (161)
Early-stage companies (278)
Established companies (465)
The majority of these companies is located in the following countries.
United States (514)
United Kingdom (75)
China (43)
Canada (42)
Example Companies
Find companies in your areaSeismic Bio Seismic Bio, Inc.

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Advaccine Beijing Advaccine Biotechnology.

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
An emerging biotech company with the next generation technology on therapeutic vaccines. View TECHNOLOGY Advaccine Biotech See our pipeline for RSV ...
biotech company focused on discovery of new vaccines, both preventive and therapeutic. Three R&D centers are in Beijing Haidian, Suzhou Biobay and Shanghai ...
pipeline consists RSV Vaccine, T1D Therapeutic Vaccine, HBV Therapeutic Vaccine, etc. Future Technology We believe, therapeutic vaccines will be the solution
Therapeutic Systems

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
AptaTargets

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
biotechnology company specialized in therapeutic aptamers aptaTargets A clinical-stage company focused in developing therapeutic applications based in aptamer
the co-founder and CEO of Aptus Biotech, an aptamer platform focused on therapeutic and diagnostic applications. aptaTargets is a spinout from Aptus Biotech ...
Eugenia has been Co-founder and operations manager at Aptus Biotech (therapeutic and diagnostic applications based on aptamers), CLO at Igen Biotech (Genetic ...
characterization of the oligonucleotide-protein interactions to identify potential therapeutic targets. He has spent more than 15 years working on molecular biology ...
the co-founder and CEO of Aptus Biotech, an aptamer platform focused on therapeutic and diagnostic applications. aptaTargets is a spinout from Aptus Biotech ...
Eugenia has been Co-founder and operations manager at Aptus Biotech (therapeutic and diagnostic applications based on aptamers), CLO at Igen Biotech (Genetic ...
translational biomarkers, global Clinical Research I-II-III-IV within therapeutic areas of psychiatry, neurology and paediatrics and Clinical Operations
SAJE Pharma

Access
- Technologies
- Core data such as location, employees, revenues
- Similar and peer companies
- and more
Web Quotes
Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical ...
Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical ...
Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits What's New at SAJE this Year New Therapeutic Activities New ...
New Therapeutic Activities New Therapeutic Activities Identified 56 therapeutic activities of GSNO and GSNORis, including SPL-850 in ocular, autoimmune ...
and metabolic disease. Read More Patent Fillings New Therapeutic Activities New Therapeutic Activities Filed wide international patent rights for SPL-850 ...
cardiovascular, and fibrotic diseases. Read More Safety & PK New Therapeutic Activities Safety & PK Clean safety data for SPL-850. Novel PK/PD for
signal and other critical proteins to regulate them · Identified 56 therapeutic activities of GSNO and GSNORis, including SPL-850 (see list under the ...
safe replacement for steroids in ocular and other therapeutic application 2. Strong oral therapeutic activity in an IBD model equal to or better than two ...
two standard of care drugs. These data add to the list of autoimmune therapeutic activities of GSNORis and suggest that SPL-850 could become a safe, autoimmune ...
alternative to existing drugs including steroids, with more mechanisms of therapeutic action · Targeted clinical trials in Autoimmune Conjunctivitis and Dry
Topics
Search by any topicOnly spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.
Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.
The following topics addressed by the majority of companies help you discover major players in the field.
- AACR
- Anti-Tumor
- Apoptosis
- Biology
- Biopharmaceutical
- Biopharmaceutical-Company
- Biopharmaceutical-Company-Focused
- Biopharmaceutical-Industry
- Biotech
- Biotechnology
- Clinical-Development
- Clinical-Stage
- Clinical-Stage-Biopharmaceutical
- Clinical-Trials
- Cytokines
- Drug-Candidates
- Drug-Designation
- Drug-Development
- Efficacy
- FDA
- Growth-Factor
- Healthcare-Conference
- High-Unmet
- Immuno-Oncology
- Ligand
- Molecular
- Monoclonal-Antibody
- Oncology
- Open-Label
- Orphan-Drug
- Orphan-Drug-Designation
- PhD
- Pharma
- Pharmacokinetics
- Pipeline
- Placebo-Controlled
- Preclinical
- Preclinical-Development
- Preclinical-Studies
- Primary-Endpoint
- Product-Candidates
- Product-Pipeline
- Protein
- Safety-Profile
- Significant-Unmet
- Small-Molecule
- Solid-Tumors
- Stage-Biopharmaceutical
- Stage-Biopharmaceutical-Company
- Tolerability
- Unmet-Medical
- Unmet-Medical-Needs
- Well-Tolerated
Use Cases
Register nowTechnology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.
Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.